FASENRA Regulatory Postmarketing Surveillance in Korea

Clinical trial NCT05091333 · COMPLETED

Trial details

NCT number: NCT05091333
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis)

Start date: 2022-03-11
Primary completion: 2025-03-06
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.